April 21-27 | Los Angeles

2018 AAN Annual Meeting

Advancing Neurology, Advancing You

The early registration deadline has passed.

The hotel deadline has passed.

70th Anniversary Celebration Ticket Information

NeuroSAE: 2018 Annual Meeting Edition

Planning to attend the 2018 AAN Annual Meeting? Assess your knowledge in major clinical areas of neurology, earn 10 free self-assessment CME, and build your itinerary for the week with this convenient online exam. FREE for all members!

How It Works

Step 1: Pre- Test

Step 2: Annual Meeting 

Step 3: Exam

Complete the pre-test prior to the meeting. You'll receive course suggestions to help you build your Annual Meeting itinerary.

Take pre-test before:
April 21, 2018

Attend the 2018 AAN Annual Meeting in Los Angeles, CA, and take part in the recommended course(s) from the pre-test.

Important Dates:
April 21-27, 2018

 Complete the post-test to gauge your improvement. Earn a score of 70% or higher and receive 10 free self-assessment CME credits.

Take exam before:
July 27, 2018


  • Designed to aid members in building a personalized learning plan for the 2018 Annual Meeting.
  • Written by neurologists for neurologists, with all-new questions that differ from previous NeuroSAE versions.
  • Questions based on the ABPN content outline for the cognitive expertise component (Part III) of MOC.
  • Pre-test results offer peer comparison and recommendations for Annual Meeting course selections based on your strengths and areas in need of improvement.
  • Convenient online format, take on your own time, at your own pace. Mobile access also available.

Learning Objectives

  • Identify major clinical areas of neurology that require more focused study and review.
  • Evaluate areas of strength and weakness and consult educational resources for self-education and improvement.
  • Apply new and reviewed information derived from the exam and resources into clinical practice to provide optimal patient care.

Core Competencies

  • Medical Knowledge

All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved.

See complete Terms of Use.

The American Academy of Neurology (AAN) is not requesting any individually identifiable information. The data you submit to the AAN through the NeuroSAE® is de-identified, as it neither identifies nor provides a reasonable basis to identify an individual. All information submitted to the AAN through NeuroSAE® is confidential. Data may be used and presented anonymously and in aggregate by the AAN.

ABPN Approved Activity

The American Board of Psychiatry and Neurology (ABPN) has reviewed and approved this product as part of a comprehensive lifelong learning program, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of maintenance of certification (MOC).

The American Academy of Neurology Institute (AANI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME). The AAN holds Accreditation with Commendation, the ACCME highest level of recognition for a CME provider.


NeuroSAE Annual Meeting Work Group

Ericka Simpson, MD, FAAN, Chair
Houston Methodist Hospital, Houston, TX
*Dr. Simpson has nothing to disclose.

Hossein Ansari, MD, FAAN
Director of Headache Clinic. University of California, San Diego, CA 
*Dr. Ansari has received personal compensation as a speaker for Avanir Pharmaceuticals

Patrick Landazuri, MD

Clinical Assistant Professor, University of Kansas School of Medicine, Kansas City, KS
*Dr. Landazuri has nothing to disclose.

Sheetal Shroff, MD
Houston Methodist Hospital, Houston, TX
*Dr. Shroff has nothing to disclose

Jonathan Cheponis, MD
Rush University, Chicago, IL
*Dr. Cheponis has nothing to disclose

Rajan Gadhia, MD
Houston Methodist Hospital, Pearland, TX
*Dr. Gadhia has nothing to disclose

NeuroSAE Staff

Amanda Chamberlain 
Sr. Manager, eLearning
Minneapolis, Minnesota
*Ms. Chamberlain has nothing to disclose.

Kristina Fosse
Sr. Administrator, eLearning
Minneapolis, Minnesota
*Ms. Fosse has nothing to disclose.

*Relationship Disclosure
+ Unlabeled Use of Products/Investigational Use Disclosure

Date of Release: November 9, 2017. Duration Statement: This exam is eligible for CME credits for three years from the release date.